(Q30151390)

English

Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 June 2017

Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012. (English)

1 reference

Europe PubMed Central

7 June 2017

1 reference

based on heuristic

inferred from title

Thomas W Hennessy

5

object named as

Thomas W Hennessy

1 reference

Europe PubMed Central

7 June 2017

Martin I Meltzer

3

object named as

Martin I Meltzer

1 reference

Europe PubMed Central

7 June 2017

Michael G Bruce

4

object named as

Michael G Bruce

1 reference

Europe PubMed Central

7 June 2017

2

object named as

Lisa R Bulkow

1 reference

Europe PubMed Central

7 June 2017

Brian J. McMahon

9

object named as

Brian J McMahon

1 reference

Europe PubMed Central

7 June 2017

Philip R Spradling

7

object named as

Philip R Spradling

1 reference

Europe PubMed Central

7 June 2017

1

object named as

Prabhu P Gounder

1 reference

Europe PubMed Central

7 June 2017

Mary M Snowball

6

object named as

Mary Snowball

1 reference

Europe PubMed Central

7 June 2017

author name string

Bishwa B Adhikari

8

1 reference

Europe PubMed Central

7 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2016

1 reference

Europe PubMed Central

7 June 2017

International Journal of Circumpolar Health

1 reference

Europe PubMed Central

7 June 2017

75

1 reference

Europe PubMed Central

7 June 2017

31115

1 reference

Europe PubMed Central

7 June 2017

1

1 reference

Europe PubMed Central

7 June 2017

Public perceptions of private health care in socialist China

1 reference

https://api.crossref.org/works/10.3402%2FIJCH.V75.31115

21 January 2018

Screening for liver cancer: the rush to judgment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Management of hepatocellular carcinoma: An update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Chronic hepatitis B: update 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Privatization and its discontents--the evolving Chinese health care system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Randomized controlled trial of screening for hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Alphafetoprotein: an obituary.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4873562

26 November 2018

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/27197711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3402/IJCH.V75.31115

1 reference

Europe PubMed Central

7 June 2017

0 references

1 reference

Europe PubMed Central

7 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30151390&oldid=1739855482"